의약품 용출 시험 서비스 시장 : 세계 산업 규모, 점유율, 동향, 기회, 예측 - 서비스 방법별, 용출 기구별, 제형별, 지역별, 경쟁별(2020-2030년)
Pharmaceutical Dissolution Testing Services Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Services Method, By Dissolution Apparatus, By Dosage Form, By Region and Competition, 2020-2030F
상품코드:1728267
리서치사:TechSci Research
발행일:2025년 05월
페이지 정보:영문 180 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
한글목차
의약품 용출 시험 서비스 세계 시장은 2024년에 7억 234만 달러에서 2030년에는 11억 3,414만 달러에 달할 것으로 예상되며, 예측 기간 동안 8.31%의 CAGR로 성장할 것으로 예상됩니다.
제약 업계가 의약품의 품질, 규제 준수 및 치료 효과를 우선시함에 따라 용출 시험 서비스에 대한 수요가 증가하고 있습니다. 이러한 서비스는 의약품 개발 및 품질 관리에 필수적이며, 고형 제제의 용출 속도, 생체 이용률 및 in vivo 성능에 대한 인사이트를 제공합니다. 용출 시험은 체내 약물 방출을 시뮬레이션하여 제조업체가 일관성, 안전성 및 치료 효과를 보장하는 데 도움이 됩니다. 전 세계적으로 규제 프레임워크가 점점 더 엄격해짐에 따라 용출 시험은 필수 기준이 되어 시장 수요를 더욱 증가시키고 있습니다. 의약품의 용출 프로파일을 지속적으로 모니터링함으로써 제약 회사는 제형과 제조 공정을 개선하고 제품의 신뢰성을 향상시키는 데 기여할 수 있습니다. 보다 복잡하고 혁신적인 제제가 개발됨에 따라, 용출 시험 서비스는 규제 당국 신청 및 배치 간 일관성을 지원하는 데 필수적이며, 의약품 연구 개발 및 품질 보증의 중요한 요소로 자리 잡고 있습니다.
시장 개요
예측 기간
2026-2030년
시장 규모 : 2024년
7억 234만 달러
시장 규모 : 2030년
11억 3,414만 달러
CAGR : 2025-2030년
8.31%
급성장 부문
태블릿
최대 시장
북미
주요 시장 촉진요인
의약품 연구개발 증가
주요 시장 과제
규제 준수
주요 시장 동향
의약품 개발 활동 증가
목차
제1장 제품 개요
제2장 조사 방법
제3장 주요 요약
제4장 고객의 소리
제5장 세계의 의약품 용출 시험 서비스 시장 전망
시장 규모 및 예측
금액별
시장 점유율과 예측
서비스 방법별(in vitro, in vivo)
용해 기구별(바스켓, 패들, 기타)
제형별(캡슐, 정제, 기타)
기업별(2024년)
지역별
시장 맵
제6장 북미의 의약품 용출 시험 서비스 시장 전망
시장 규모 및 예측
시장 점유율과 예측
북미 : 국가별 분석
미국
멕시코
캐나다
제7장 유럽의 의약품 용출 시험 서비스 시장 전망
시장 규모 및 예측
시장 점유율과 예측
유럽 : 국가별 분석
프랑스
독일
영국
이탈리아
스페인
제8장 아시아태평양의 의약품 용출 시험 서비스 시장 전망
시장 규모 및 예측
시장 점유율과 예측
아시아태평양 : 국가별 분석
중국
인도
한국
일본
호주
제9장 남미의 의약품 용출 시험 서비스 시장 전망
시장 규모 및 예측
시장 점유율과 예측
남미 : 국가별 분석
브라질
아르헨티나
콜롬비아
제10장 중동 및 아프리카의 의약품 용출 시험 서비스 시장 전망
시장 규모 및 예측
시장 점유율과 예측
중동 및 아프리카 : 국가별 분석
남아프리카공화국
사우디아라비아
아랍에미리트
제11장 시장 역학
성장 촉진요인
과제
제12장 시장 동향과 발전
최근 동향
제품 출시
인수합병
제13장 PESTEL 분석
제14장 Porter's Five Forces 분석
업계내 경쟁
신규 참여의 가능성
공급업체의 능력
고객의 능력
대체품의 위협
제15장 경쟁 구도
Intertek Group Plc
Avivia BV
Almac Group
Agilent Technologies, Inc.
Catalent, Inc.
Thermofisher Scientific Inc.
Charles River Laboratories
Cambrex
Boston Analytical
Pace Analytical Life Sciences
제16장 전략적 제안
제17장 조사 회사 소개 및 면책사항
ksm
영문 목차
영문목차
The Global Pharmaceutical Dissolution Testing Services Market was valued at USD 702.34 Million in 2024 and is projected to reach USD 1134.14 Million by 2030, growing at a CAGR of 8.31% during the forecast period. As the pharmaceutical industry prioritizes drug quality, regulatory adherence, and therapeutic efficacy, the demand for dissolution testing services is on the rise. These services are vital in drug development and quality control, providing insights into the dissolution rate, bioavailability, and in vivo performance of solid dosage forms. Dissolution testing simulates the release of a drug in the body, helping manufacturers ensure consistency, safety, and therapeutic effectiveness. Increasingly stringent global regulatory frameworks have made dissolution testing a mandatory standard, further driving market demand. Through continuous monitoring of drug dissolution profiles, pharmaceutical firms can refine formulations and manufacturing processes, contributing to enhanced product reliability. As more complex and innovative drug formulations enter development, dissolution testing services are becoming indispensable in supporting regulatory submissions and batch-to-batch consistency, making them a critical component of pharmaceutical R&D and quality assurance.
Market Overview
Forecast Period
2026-2030
Market Size 2024
USD 702.34 Million
Market Size 2030
USD 1134.14 Million
CAGR 2025-2030
8.31%
Fastest Growing Segment
Tablets
Largest Market
North America
Key Market Drivers
Rising Pharmaceutical R&D
The growth of pharmaceutical research and development is a key factor propelling the Global Pharmaceutical Dissolution Testing Services Market. With increasing investment in novel drug development and therapeutic innovation, the role of dissolution testing has become integral to optimizing formulations, assessing drug bioavailability, and ensuring production consistency. The surge in new drug candidates across therapeutic areas demands robust testing solutions to meet regulatory and clinical standards. According to the OECD, global pharmaceutical R&D expenditure reached USD 129 billion in 2021, with the United States contributing the majority share. This upward trend is reinforced by rapid R&D expansion in countries like China, which recorded a 189% increase in pharmaceutical research spending between 2010 and 2019. As R&D activity accelerates globally, the need for specialized testing services, particularly in dissolution studies, is rising, ensuring compliance, safety, and therapeutic performance in increasingly complex drug products.
Key Market Challenges
Regulatory Compliance
Regulatory compliance remains a significant challenge for the pharmaceutical dissolution testing services market. With evolving guidelines from global authorities such as the U.S. FDA and EMA, testing laboratories must stay updated with the latest requirements for drug evaluation. Adhering to these standards necessitates significant investment in training, advanced instrumentation, and meticulous documentation. Non-compliance can result in regulatory penalties, delays in product approvals, or product recalls, affecting a company's market standing and operational costs. As compliance expectations grow more stringent, service providers must continuously adapt their processes, ensuring accuracy, traceability, and alignment with international regulatory frameworks. The constant evolution of compliance benchmarks places a considerable operational and financial burden on testing organizations, making regulatory alignment a critical success factor in the dissolution testing services market.
Key Market Trends
Increasing Drug Development Activities
The escalating pace of drug development is driving increased demand for pharmaceutical dissolution testing services. With the pharmaceutical industry expanding its focus on targeted therapies, biologics, and controlled-release formulations, the need for precise and reliable dissolution testing is more crucial than ever. These tests play a vital role in formulation development, quality control, and regulatory approval. Modern formulations, including nanoparticles and extended-release systems, require specialized dissolution assessments to ensure accurate drug performance analysis. Regulatory agencies demand rigorous documentation of dissolution profiles during the drug approval process, reinforcing the value of expert testing services. Additionally, outsourcing testing to specialized providers offers pharmaceutical companies cost efficiency, flexibility, and access to technical expertise. This growing trend, fueled by a focus on time and resource optimization, is expected to support the sustained expansion of the dissolution testing services market.
Key Market Players
Intertek Group Plc
Avivia BV
Almac Group
Agilent Technologies, Inc.
Catalent, Inc.
Thermo Fisher Scientific Inc
Charles River Laboratories
Cambrex
Boston Analytical
Pace Analytical Life Sciences
Report Scope:
In this report, the Global Pharmaceutical Dissolution Testing Services Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Pharmaceutical Dissolution Testing Services Market, By Services Method:
In vitro
In vivo
Pharmaceutical Dissolution Testing Services Market, By Dosage Form:
Capsule
Tablets
Others
Pharmaceutical Dissolution Testing Services Market, By Dissolution Apparatus:
Basket
Paddle
Others
Pharmaceutical Dissolution Testing Services Market, By Region:
North America
United States
Canada
Mexico
Europe
France
United Kingdom
Italy
Germany
Spain
Asia-Pacific
China
India
Japan
Australia
South Korea
South America
Brazil
Argentina
Colombia
Middle East & Africa
South Africa
Saudi Arabia
UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the Global Pharmaceutical Dissolution Testing Services Market.
Available Customizations:
Global Pharmaceutical Dissolution Testing Services market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
Detailed analysis and profiling of additional market players (up to five).
Table of Contents
1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Global Pharmaceutical Dissolution Testing Services Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Services Method (In vitro, In vivo)
5.2.2. By Dissolution Apparatus (Basket, Paddle, Others)
5.2.3. By Dosage Form (Capsule, Tablets, Others)
5.2.4. By Company (2024)
5.2.5. By Region
5.3. Market Map
6. North America Pharmaceutical Dissolution Testing Services Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Services Method
6.2.2. By Dissolution Apparatus
6.2.3. By Dosage Form
6.2.4. By Country
6.3. North America: Country Analysis
6.3.1. United States Pharmaceutical Dissolution Testing Services Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Services Method
6.3.1.2.2. By Dissolution Apparatus
6.3.1.2.3. By Dosage Form
6.3.2. Mexico Pharmaceutical Dissolution Testing Services Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Services Method
6.3.2.2.2. By Dissolution Apparatus
6.3.2.2.3. By Dosage Form
6.3.3. Canada Pharmaceutical Dissolution Testing Services Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Services Method
6.3.3.2.2. By Dissolution Apparatus
6.3.3.2.3. By Dosage Form
7. Europe Pharmaceutical Dissolution Testing Services Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Services Method
7.2.2. By Dissolution Apparatus
7.2.3. By Dosage Form
7.2.4. By Country
7.3. Europe: Country Analysis
7.3.1. France Pharmaceutical Dissolution Testing Services Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Services Method
7.3.1.2.2. By Dissolution Apparatus
7.3.1.2.3. By Dosage Form
7.3.2. Germany Pharmaceutical Dissolution Testing Services Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Services Method
7.3.2.2.2. By Dissolution Apparatus
7.3.2.2.3. By Dosage Form
7.3.3. United Kingdom Pharmaceutical Dissolution Testing Services Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Services Method
7.3.3.2.2. By Dissolution Apparatus
7.3.3.2.3. By Dosage Form
7.3.4. Italy Pharmaceutical Dissolution Testing Services Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Services Method
7.3.4.2.2. By Dissolution Apparatus
7.3.4.2.3. By Dosage Form
7.3.5. Spain Pharmaceutical Dissolution Testing Services Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Services Method
7.3.5.2.2. By Dissolution Apparatus
7.3.5.2.3. By Dosage Form
8. Asia-Pacific Pharmaceutical Dissolution Testing Services Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Services Method
8.2.2. By Dissolution Apparatus
8.2.3. By Dosage Form
8.2.4. By Country
8.3. Asia-Pacific: Country Analysis
8.3.1. China Pharmaceutical Dissolution Testing Services Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Services Method
8.3.1.2.2. By Dissolution Apparatus
8.3.1.2.3. By Dosage Form
8.3.2. India Pharmaceutical Dissolution Testing Services Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Services Method
8.3.2.2.2. By Dissolution Apparatus
8.3.2.2.3. By Dosage Form
8.3.3. South Korea Pharmaceutical Dissolution Testing Services Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Services Method
8.3.3.2.2. By Dissolution Apparatus
8.3.3.2.3. By Dosage Form
8.3.4. Japan Pharmaceutical Dissolution Testing Services Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Services Method
8.3.4.2.2. By Dissolution Apparatus
8.3.4.2.3. By Dosage Form
8.3.5. Australia Pharmaceutical Dissolution Testing Services Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Services Method
8.3.5.2.2. By Dissolution Apparatus
8.3.5.2.3. By Dosage Form
9. South America Pharmaceutical Dissolution Testing Services Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Services Method
9.2.2. By Dissolution Apparatus
9.2.3. By Dosage Form
9.2.4. By Country
9.3. South America: Country Analysis
9.3.1. Brazil Pharmaceutical Dissolution Testing Services Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Services Method
9.3.1.2.2. By Dissolution Apparatus
9.3.1.2.3. By Dosage Form
9.3.2. Argentina Pharmaceutical Dissolution Testing Services Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Services Method
9.3.2.2.2. By Dissolution Apparatus
9.3.2.2.3. By Dosage Form
9.3.3. Colombia Pharmaceutical Dissolution Testing Services Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Services Method
9.3.3.2.2. By Dissolution Apparatus
9.3.3.2.3. By Dosage Form
10. Middle East and Africa Pharmaceutical Dissolution Testing Services Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Services Method
10.2.2. By Dissolution Apparatus
10.2.3. By Dosage Form
10.2.4. By Country
10.3. MEA: Country Analysis
10.3.1. South Africa Pharmaceutical Dissolution Testing Services Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Services Method
10.3.1.2.2. By Dissolution Apparatus
10.3.1.2.3. By Dosage Form
10.3.2. Saudi Arabia Pharmaceutical Dissolution Testing Services Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Services Method
10.3.2.2.2. By Dissolution Apparatus
10.3.2.2.3. By Dosage Form
10.3.3. UAE Pharmaceutical Dissolution Testing Services Market Outlook